Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 19, 2018

DrugPatentWatch Database Preview

Amneal Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for AMNEAL PHARMS, and what generic and branded alternatives to AMNEAL PHARMS drugs are available?

AMNEAL PHARMS has one hundred and eighty approved drugs.

There are twelve tentative approvals on AMNEAL PHARMS drugs.

Summary for Amneal Pharms

US Patents:	0
Tradenames:	138
Ingredients:	133
NDAs:	180

Drugs and US Patents for Amneal Pharms

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amneal Pharms Co	BUSULFAN	busulfan	INJECTABLE;INJECTION	209580-001	Dec 18, 2017	AP	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Amneal Pharms	VALSARTAN	valsartan	TABLET;ORAL	204011-004	Jan 11, 2016	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Amneal Pharms	MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE	donepezil hydrochloride; memantine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	208328-002	Jan 27, 2017	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Amneal Pharms	VIGABATRIN	vigabatrin	FOR SOLUTION;ORAL	210155-001	Mar 13, 2018	AA	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Amneal Pharms

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Amneal Pharms Llc	ACTIVELLA	estradiol; norethindrone acetate	TABLET;ORAL	020907-001	Nov 18, 1998	RE36247	➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Paragraph IV (Patent) Challenges for AMNEAL PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck

AstraZeneca

Farmers Insurance

McKesson

UBS

Harvard Business School

Daiichi Sankyo

Deloitte

McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.